Cholinergic dysfunction in Alzheimer disease: cause or effect?

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Progress in Brain Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0079-6123(08)60644-5PMID 2878469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Muscarinic receptor compensation in hippocampus of Alzheimer patients

  2005cited by this paper
• Lecithin and piracetam in Alzheimer's disease.

  1987cited by this paper
• A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.

  1984cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease.

  1984cited by this paper
• 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine destroys dopamine neurons in explants of rat embryo mesencephalon.

  1984cited by this paper
• Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

  1984cited by this paper
• Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease.

  1984cited by this paper
• Neurochemical Pathology of Alzheimer's Disease - The Cholinergic Concept

  1984cited by this paper
• Neurochemical characteristics of early and late onset types of Alzheimer's disease.

  1984cited by this paper
• The basal nucleus of Meynert in patients with progressive supranuclear palsy.

  1984cited by this paper
• Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.

  1984cited by this paper
• Neurobiology of Alzheimer's Disease

  1984cited by this paper
• Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease.

  1984cited by this paper
• Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain

  1984cited by this paper
• Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia.

  1984cited by this paper
• AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat.

  1984cited by this paper
• Neural inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey.

  1984cited by this paper
• Intrahippocampal septal grafts ameliorate learning impairments in aged rats.

  1984cited by this paper
• Reduction in muscarinic receptor binding in limbic areas of Alzheimer brain.

  1984cited by this paper
• Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.

  1983cited by this paper
• Measurement of cholinergic drug effects on memory in Alzheimer's disease.

  1983cited by this paper
• Fragment red cells in disseminated intravascular coagulation.

  1983cited by this paper
• Effects of lecithin on EEG and blood levels of choline.

  1983cited by this paper
• Choline and cholinergic neurons.

  1983cited by this paper
• Memory enhancement with oral physostigmine in Alzheimer's disease.

  1983cited by this paper
• Basal nucleus of Meynert: a neuropathological study in Alzheimer's disease, simple senile dementia, Pick's disease and Huntington's chorea.

  1983cited by this paper
• Senile dementia of the Alzheimer type

  1983cited by this paper
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1983cited by this paper
• Organization and morphological characteristics of cholinergic neurons: an immunocytochemical study with a monoclonal antibody to choline acetyltransferase.

  1983cited by this paper
• Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

  1983cited by this paper
• Effects of naloxone in senile dementia: a double-blind trial.

  1983cited by this paper
• Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.

  1983cited by this paper
• Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

  1983cited by this paper
• Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroups

  1983cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• Basal forebrain neurons in the dementia of Parkinson disease

  1983cited by this paper
• Age and Alzheimer disease.

  1983cited by this paper
• Pick's disease (lobar sclerosis)

  1983cited by this paper
• Neuron loss in the nucleus basalis of meynert in parkinsonism‐dementia complex of Guam

  1983cited by this paper
• Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients.

  1983cited by this paper
• Elevation of erythrocyte countertransport rates in Alzheimer's dementia.

  1983cited by this paper
• The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.

  1982cited by this paper
• Cholinergic innervation in neuritic plaques.

  1982cited by this paper
• Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

  1982cited by this paper
• Lecithin and memory training in suspected Alzheimer's disease.

  1982cited by this paper
• A post-mortem study of the cholinergic and GABA systems in senile dementia.

  1982cited by this paper
• Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.

  1982cited by this paper
• The noradrenergic system in Alzheimer and multi-infarct dementias.

  1982cited by this paper
• A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease.

  1982cited by this paper
• Alzheimer's disease : a report of progress in research

  1982cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• Lithium, memory and RBC/plasma choline in Alzheimer-type dementia

  1982cited by this paper
• Intrusions as a sign of Alzheimer dementia chemical and pathological verification

  1982cited by this paper
• Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

  1982cited by this paper
• Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia

  1982cited by this paper
• Piracetam diminishes hippocampal acetylcholine levels in rats.

  1981cited by this paper
• Alzheimer disease

  1981cited by this paper
• Neocortical cholinergic innervation: A description of extrinsic and intrinsic components in the rat

  1981cited by this paper
• Noradrenergic and cholinergic systems in senile dementia of Alzheimer type.

  1981cited by this paper
• Presynaptic cholinergic mechanisms in brain of aged rats with memory impairments.

  1981cited by this paper
• NORADRENERGIC AND CHOLINERGIC SYSTEMS IN SENILE DEMENTIA OF ALZHEIMER TYPE

  1981cited by this paper
• Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

  1981cited by this paper
• Strategies For the development of an Effective Treatment for Senile Dementia

  1981cited by this paper
• Cell loss in the locus coeruleus in senile dementia of Alzheimer type.

  1981cited by this paper
• Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats.

  1981cited by this paper
• Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile Dementia

  1981cited by this paper
• Sympathetic noradrenergic sprouting in response to central cholinergic denervation; a histochemical study of neuronal sprouting in the rat hippocampal formation.

  1981cited by this paper
• Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients.

  1981cited by this paper
• Aging Decreases Oxidative Metabolism and the Release and Synthesis of Acetylcholine

  1981cited by this paper
• A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease

  1981cited by this paper
• Clinical response to choline plus piracetam in senile dementia: relation to red-cell choline level.

  1981cited by this paper
• Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease

  1981cited by this paper
• Choline chloride fails to improve cognition of Alzheimer's disease.

  1981cited by this paper
• Age-related changes in passive avoidance retention: modulation with dietary choline.

  1980cited by this paper
• Dementia of the Alzheimer type.

  1980cited by this paper
• Memory and cognitive function in the elderly. A preliminary trial of physostigmine.

  1980cited by this paper
• Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

  1980cited by this paper
• Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia

  1980cited by this paper
• The polymorphism of cholinesterases and its physiological significance

  1980cited by this paper
• Histochemical observations on cholinesterase activities in the brains of elderly normal and demented (Alzheimer-type) patients.

  1980cited by this paper
• Norepinephrine and gamma‐aminobutyric acid in amyotrophic lateral sclerosis

  1980cited by this paper
• Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.

  1980cited by this paper
• Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.

  1980cited by this paper
• Effect of physostigmine on constructional and memory tasks in Alzheimer's disease.

  1979cited by this paper
• Enhancement of memory by physostigmine.

  1979cited by this paper
• Accelerated ageing or selective neuronal loss as an important cause of dementia?

  1979cited by this paper
• Pain sensitivity in schizophrenics.

  1979cited by this paper
• Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.

  1979cited by this paper
• Evidence for a cholinergic projection to neocortex from neurons in basal forebrain.

  1979cited by this paper
• Physostigmine: improvement of long-term memory processes in normal humans.

  1978cited by this paper
• Pre- and postsynaptic neurochemical alterations in Alzheimer's disease.

  1978cited by this paper
• Human serial learning: enhancement with arecholine and choline impairment with scopolamine.

  1978cited by this paper
• Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigmine and methylphenidate with scopolamine.

  1978cited by this paper
• Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

  1978cited by this paper
• A double-blind investigation of piracetam (nootropil) versus placebo in the memory of geriatric inpatients.

  1978cited by this paper
• Necropsy evidence of central cholinergic deficits in senile dementia.

  1977cited by this paper
• Neocortical cholinergic neurons in elderly people.

  1977cited by this paper
• Memory and cognitive function in man

  1977cited by this paper

• New perspectives on the basal forebrain cholinergic system in Alzheimer's disease.

  2023cites this paper
• COVID-19: Energy, Protein Folding & Prion Disease

  2022cites this paper
• Eriodictyol Attenuates LPS-Induced Neuroinflammation, Amyloidogenesis, and Cognitive Impairments via the Inhibition of NF-κB in Male C57BL/6J Mice and BV2 Microglial Cells.

  2018cites this paper
• Cognition enhancing effect of the aqueous extract of Cinnamomum zeylanicum on non-transgenic Alzheimer's disease rat model: Biochemical, histological, and behavioural studies

  2017cites this paper
• Chicoric acid supplementation prevents systemic inflammation‐induced memory impairment and amyloidogenesis via inhibition of NF‐κB

  2017influential citation
• GSK-3β, a pivotal kinase in Alzheimer disease

  2014cites this paper
• Roles of glycogen synthase kinase 3 in Alzheimer's disease.

  2012cites this paper
• Altered cholinergic metabolism and muscarinic receptor linked second messenger pathways after chronic exposure to dichlorvos in rat brain

  2007cites this paper
• Reversal effect of DM-9384 on scopolamine-induced acetylcholine depletion in certain regions of the mouse brain

  2005cites this paper
• MKC-231, a choline uptake enhancer, ameliorates working memory deficits and decreased hippocampal acetylcholine induced by ethylcholine aziridinium ion in mice

  2005cites this paper
• Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF64A in mice

  2005cites this paper
• Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders

  2003cites this paper
• Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function.

  2003cites this paper
• The study of behavioral dysfunctions: an evaluation of selected animal models

  2000influential citation
• Tau Protein in Normal and Alzheimer's Disease Brain

  1999cites this paper
• Neurotransmitterveränderungen bei der Alzheimer Demenz

  1999cites this paper
• Effects of clausenamide on anisodine-induced acetylcholine decrease and memory deficits in the mouse brain.

  1998cites this paper
• Acetylcholinesterase inhibitors block acetylcholine-evoked release of dopamine in rat striatum, in vivo.

  1996cites this paper
• Altered Cholinergic Metabolism in Rat CNS Following Aluminum Exposure: Implications on Learning Performance

  1995cites this paper
• A double‐blind, placebo‐controlled, enriched population study of tacrine in patients with Alzheimer's disease

  1995cites this paper
• Attempts to make models for Alzheimer's disease.

  1992cites this paper
• The effect of long-term high dose lecithin on erythrocyte choline transport in Alzheimer patients.

  1992cites this paper
• Behavioral consequences of chronic dietary choline enrichment

  1989cites this paper
• Drug treatment of dementia

  1989cites this paper
• Cognition activators

  1988cites this paper